Login / Signup

A novel urinary mRNA signature using the droplet digital polymerase chain reaction platform improves discrimination between prostate cancer and benign prostatic hyperplasia within the prostate-specific antigen gray zone.

Ho Won KangHee Youn LeeYoung Joon ByunPildu JeongJin Sun YoonDong Ho KimWon Tae KimYong-June KimSang-Cheol LeeSeok-Joong YunWun Jae Kim
Published in: Investigative and clinical urology (2020)
The data demonstrate that the UMPCaRS is useful for discriminating between PCa and BPH in the "PSA gray zone".
Keyphrases
  • benign prostatic hyperplasia
  • prostate cancer
  • lower urinary tract symptoms
  • radical prostatectomy
  • high throughput
  • electronic health record
  • single cell
  • big data
  • binding protein
  • data analysis
  • machine learning